导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 18.70% | 212/1050 |
| 近一周 | -1.94% | 380/1104 |
| 近一月 | -4.76% | 589/1102 |
| 近一季 | 28.42% | 13/1092 |
| 近半年 | 21.58% | 126/1070 |
| 近一年 | 2.45% | 523/1018 |
| 近两年 | 65.43% | 388/926 |
| 近三年 | 29.89% | 394/834 |
| 成立以来 | 67.55% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
1.53% 377/1070 |
1.92% 660/1101 |
- - |
- - |
| 2025 | 25.94% 569/1065 |
5.12% 405/1014 |
11.34% 73/1038 |
27.14% 408/1050 |
-15.36% 988/1065 |
| 2024 | -12.18% 808/1011 |
-10.65% 785/960 |
-4.13% 579/983 |
12.94% 387/991 |
-9.23% 880/1011 |
| 2023 | -13.29% 448/952 |
-2.36% 727/880 |
-11.09% 792/895 |
3.22% 16/915 |
-3.23% 344/952 |
| 2022 | -17.78% 248/867 |
-13.83% 211/773 |
10.27% 256/806 |
-20.04% 754/845 |
8.21% 114/867 |
| 2021 | -2.82% 393/740 |
3.38% 72/580 |
21.70% 135/659 |
-7.99% 449/704 |
-16.04% 691/740 |
| 2020 | 79.69% 93/554 |
19.45% 8/419 |
35.86% 60/466 |
6.72% 327/517 |
3.75% 456/554 |
| 2019 | 59.97% 82/410 |
31.28% 303/1146 |
0.71% 262/1228 |
14.24% 48/390 |
5.91% 313/410 |
| 2018 | -22.20% 103/349 |
- - |
2.63% 38/990 |
-13.54% 921/1000 |
-16.34% 931/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.53% |
| 招商医药健康产业股票 | 2.5730 | 49.25% |
| 广发医药精选股票C | 1.2923 | 40.43% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 嘉实医疗保健股票 | 2.5780 | 38.47% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 中欧医疗创新股票A | 1.6444 | 34.01% |
| 中欧医疗创新股票C | 1.5481 | 33.74% |
| 嘉实医药健康股票A VS. 东吴新产业精选股票A(580008) |